vimarsana.com

Latest Breaking News On - Avita medical chart - Page 1 : vimarsana.com

AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance

22.02.2024 - VALENCIA, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) - AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today reported .

United statesJim corbettBiomedical advanced researchDevelopment authorityDrug administrationHuman servicesUs department of healthDrug administration foodChief executivePermeaderm biosynthetic wound matrixAssistant secretaryConference callEastern daylight timeSpray on skin cellsPrivate securities litigation reform actAnnual report

AVITA Medical Updates Full Year 2023 Guidance

20.11.2023 - VALENCIA, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) - AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular .

Jim corbettValue analysis committeeChief executive officerAvita medical chartVita medical kursVita medical aktie

vimarsana © 2020. All Rights Reserved.